Business
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference
PONTE VEDRA, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will highlight new product innovations and present new interim data for the ALIGN3D™, MTA3D™, and SpeedMTP® clinical studies at the American College of Foot and Ankle Surgeons (“ACFAS”) Annual Scientific Conference in Las Veg
About this update from Treace Medical Concepts, Inc.
[{"type":"image","alt":"Treace Medical Concepts, Inc.","displaySize":"","headline":null,"caption":"Treace Medical Concepts, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":60,"url":"https://media.zenfs.com/en/globenewswire.com/d629ef51169cbf34a252b8eca6fa7363"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/vLorRmISLl3PfaqwwnfXfQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg0O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/d629ef51169cbf34a252b8eca6fa7363","width":300,"height":60}},"lazy":false},{"type":"text","content":"PONTE VEDRA, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will highlight new product innovations and present new interim data for the ALIGN3D™, MTA3D™, and SpeedMTP® clinical studies at the American College of Foot and Ankle Surgeons (“ACFAS”) Annual Scientific Conference in Las Vegas, Nevada from February 24-26, 2026.","length":537,"tagName":"p"},{"type":"text","content":"“We are proud to showcase our latest clinical data and innovations at ACFAS, including our next-generation Lapiplasty® instrumentation and fixation technology platforms,” said John T. Treace, CEO, Founder and Chairman of Treace. “These new Lapiplasty® technologies further advance our comprehensive 3D bunion solution portfolio, also featuring Nanoplasty®, Percuplasty™, SpeedMTP®, and IntelliGuide® PSI, to accelerate our penetration into the bunion market and advance our leadership position. We also look forward to sharing compelling clinical evidence from prospective, multicenter studies that continues to differentiate our flagship Lapiplasty® and Adductoplasty® procedures, as well as new retrospective clinical data on our SpeedMTP® procedure.”","length":763,"tagName":"p"},{"type":"text","content":"Treace will feature clinical data and several new technologies at our ACFAS exhibit booth and host surgeon training events on these innovations, including:","length":155,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"SpeedTMT™ Rapid Compression Implant: New at ACFAS 2026, SpeedTMT™ is our latest advancement in Lapiplasty® SpeedPlate® fixation. SpeedTMT™ utilizes our novel...